Form 4 filings across 4 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$11.5M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 14 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 39 most recent Form 4 transactions.
| Jun 24 | CNTA | Centessa Pharmaceuticals… | DTOISS◆ | 48,000 | — | — | — | Open the original filing on SEC.gov |
| Jun 24 | CNTA | Centessa Pharmaceuticals… | DTOISS◆ | 48,000 | — | — | — | Open the original filing on SEC.gov |
| Jun 24 | CNTA | Centessa Pharmaceuticals… | DTOISS◆ | 48,000 | — | — | — | Open the original filing on SEC.gov |
| Jun 24 | CNTA | Centessa Pharmaceuticals… | DTOISS◆ | 208,474 | — | — | — | Open the original filing on SEC.gov |
| Jun 2 | ORKA | Oruka Therapeutics, Inc. | AGRANT◆ | 9,136 | — | — | — | Open the original filing on SEC.gov |
| Mar 23 | CRSP | CRISPR Therapeutics AG | SSELL | 10,020 | $46.78 | $468.7K | -3.8% | Open the original filing on SEC.gov |
| Mar 20 | CRSP | CRISPR Therapeutics AG | MEXER◆ | 19,687 | — | — | — | Open the original filing on SEC.gov |
| Mar 20 | CRSP | CRISPR Therapeutics AG | AGRANT◆ | 81,875 | — | — | — | Open the original filing on SEC.gov |
| Mar 20 | CRSP | CRISPR Therapeutics AG | AGRANT◆ | 114,249 | — | — | — | Open the original filing on SEC.gov |
| Mar 20 | CRSP | CRISPR Therapeutics AG | MEXER | 19,687 | — | — | +8.0% | Open the original filing on SEC.gov |
| Mar 16 | CRSP | CRISPR Therapeutics AG | SSELL | 10,349 | $48.26 | $499.4K | -4.0% | Open the original filing on SEC.gov |
| Mar 14 | CRSP | CRISPR Therapeutics AG | MEXER◆ | 20,625 | — | — | — | Open the original filing on SEC.gov |
| Mar 14 | CRSP | CRISPR Therapeutics AG | MEXER | 20,625 | — | — | +8.8% | Open the original filing on SEC.gov |
| Mar 11 | CRSP | CRISPR Therapeutics AG | SSELL | 9,798 | $52.80 | $517.3K | -4.0% | Open the original filing on SEC.gov |
| Mar 10 | CRSP | CRISPR Therapeutics AG | MEXER◆ | 19,250 | — | — | — | Open the original filing on SEC.gov |
| Mar 10 | CRSP | CRISPR Therapeutics AG | MEXER | 19,250 | — | — | +8.5% | Open the original filing on SEC.gov |
| Feb 19 | CRSP | CRISPR Therapeutics AG | SSELL | 6,967 | $52.58 | $366.3K | -3.0% | Open the original filing on SEC.gov |
| Feb 18 | CRSP | CRISPR Therapeutics AG | MEXER◆ | 13,250 | — | — | — | Open the original filing on SEC.gov |
| Feb 18 | CRSP | CRISPR Therapeutics AG | MEXER | 13,250 | — | — | +6.0% | Open the original filing on SEC.gov |
| Jan 22 | CRSP | CRISPR Therapeutics AG | SSELL◷ | 60,000 | $60.23 | $3.6M | -30.9% | Open the original filing on SEC.gov |
| Jan 20 | CRSP | CRISPR Therapeutics AG | SSELL◷ | 8,567 | $52.10 | $446.3K | -4.2% | Open the original filing on SEC.gov |
| Jan 20 | CRSP | CRISPR Therapeutics AG | SSELL◷ | 21,433 | $51.61 | $1.1M | -9.6% | Open the original filing on SEC.gov |
| Dec 18, 2025 | CRSP | CRISPR Therapeutics AG | GGIFT | 30,000 | — | — | -11.8% | Open the original filing on SEC.gov |
| Oct 17, 2025 | CRSP | CRISPR Therapeutics AG | SSELL | 50,895 | $67.91 | $3.5M | -16.7% | Open the original filing on SEC.gov |
| Oct 16, 2025 | CRSP | CRISPR Therapeutics AG | MEXER◆ | 100,000 | — | — | — | Open the original filing on SEC.gov |
| Oct 16, 2025 | CRSP | CRISPR Therapeutics AG | MEXER | 100,000 | — | — | +48.8% | Open the original filing on SEC.gov |
| Oct 14, 2025 | CRSP | CRISPR Therapeutics AG | SSELL | 4,242 | $66.60 | $282.5K | -2.0% | Open the original filing on SEC.gov |
| Oct 13, 2025 | CRSP | CRISPR Therapeutics AG | MEXER◆ | 8,334 | — | — | — | Open the original filing on SEC.gov |
| Oct 13, 2025 | CRSP | CRISPR Therapeutics AG | MEXER | 8,334 | — | — | +4.2% | Open the original filing on SEC.gov |
| Oct 3, 2025 | CRSP | CRISPR Therapeutics AG | AGRANT◆ | 49,500 | — | — | — | Open the original filing on SEC.gov |
| Sep 17, 2025 | CRSP | CRISPR Therapeutics AG | GGIFT | 6,000 | — | — | -2.9% | Open the original filing on SEC.gov |
| Aug 18, 2025 | CRSP | CRISPR Therapeutics AG | SSELL | 13,081 | $58.15 | $760.7K | -5.9% | Open the original filing on SEC.gov |
| Aug 16, 2025 | CRSP | CRISPR Therapeutics AG | MEXER◆ | 25,000 | — | — | — | Open the original filing on SEC.gov |
| Aug 16, 2025 | CRSP | CRISPR Therapeutics AG | MEXER | 25,000 | — | — | +12.8% | Open the original filing on SEC.gov |
| Jun 20, 2025 | CNTA | Centessa Pharmaceuticals… | AGRANT◆ | 40,000 | — | — | — | Open the original filing on SEC.gov |
| Jun 12, 2025 | BDTX | Black Diamond Therapeutics… | AGRANT◆ | 30,550 | — | — | — | Open the original filing on SEC.gov |
| Jun 2, 2025 | ORKA | Oruka Therapeutics, Inc. | AGRANT◆ | 17,500 | — | — | — | Open the original filing on SEC.gov |